About Cyriac Roeding
Cyriac Roeding is a Silicon Valley–based German–American entrepreneur and investor. He serves as the co-founder and CEO of Earli, an early cancer detection and treatment firm based in Redwood City, California. Earli is based on forcing cancer to turn against itself with a genetic construct that switches on only in cancer cells and activates the immune system to attack and kill the cancer. The concept originated at Stanford University and has substantially evolved through AI and extensive bioengineering. Earli raised >$100M from by Andreessen Horowitz, Khosla Ventures, Perceptive Advisors, Casdin Capital, Sands Capital, Menlo Ventures, ZhenFund (China) and Marc Benioff. Roeding is also a co-founder and chairman of the board of Rewind Co., a diabetes type 2 reversal company. Roeding's venture investing focuses on AI, brain-to-machine interfaces, consumer businesses, biology meeting software and engineering, and consumer robotics. He served as EVP at Paramount Global / CBS, where he started the division CBS Mobile and brought it to profitability, and as an entrepreneur-in-residence at Kleiner Perkins and its iFund with Apple Inc., where he co-founded and led mobile shopping app shopkick with $22M of venture capital to a $250 million cash acquisition by SK Telecom/SK Planet and 20 million users. Shopkick rewards users for just walking into retail stores such as Target Corporation, Best Buy, Macy's and Walmart and engaging with products from Procter & Gamble, Pepsi, L'Oreal etc., driving over $1 billion in sales annually for its partners. Fast Company ranked shopkick one of the world's 10 Most Innovative Companies In Retail, alongside Apple and Starbucks, and Entrepreneur Magazine placed Roeding on its cover.
